Semaglutide — Research Peptide
Semaglutide (CAS 910463-68-2) is a synthetic 31-residue GLP-1 receptor agonist analog supplied as a lyophilized reference material for in-vitro laboratory and analytical research. Each lot is manufactured to a high specification and characterized by independent third-party HPLC for purity, with a lot-matched certificate of analysis published for every vial.
Research context
Semaglutide is studied in receptor-signaling and analytical research as a single-receptor GLP-1 reference compound. With roughly 94% sequence homology to native GLP-1, laboratories use it for comparative work alongside dual- and triple-receptor compounds, method development, and assay validation. Statements here describe research context only and do not represent any therapeutic use.
Purity and verification
Every lot undergoes independent third-party HPLC analysis before release. The certificate of analysis for the current lot is published on this page and archived at glpxlabs.com/coa.
Specifications
- Sequence: synthetic, verified (31 amino acids)
- Format: lyophilized powder
- Purity: 99%+ by HPLC (see lot COA)
- Storage (lyophilized): −20 °C, freeze, protected from light
- Storage (in solution): 2–8 °C; refrigerate
- Ships: sealed vial with lot number and certificate of analysis
Compliance
This listing is a laboratory reference compound. It is not a drug, supplement, food, or cosmetic, and is not intended for human or veterinary use, diagnostic use, or consumption of any kind. Not evaluated by the FDA. For laboratory research use only.
Also referenced as: sema peptide, GLP-1 analog, GLP-1 receptor agonist.